Publications générales et transversales

Maladies Auto-Immunes et Thérapie cellulaire – Publications générales et transversales

2018
Applied Bayesian Methods in the Rheumatic Diseases.
Johnson SR, Tomlinson GA, Granton JT, Hawker GA, Feldman BM.
Rheum Dis Clin North Am. 2018 May;44(2):361-370

2017
Le passage à l’échelle industrielle de la production de cellules souches à usage thérapeutique.
Raymond ARDAILLOU, Bruno JARRY et Jean-François STOLTZ
Académie Nationale de Médecine- Rapport de la séance du 05/12/2017

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases
John A. Snowden, Manuela Badoglio, Myriam Labopin, Sebastian Giebel, Eoin McGrath, Zora Marjanovic, Joachim Burman, John Moore, Montserrat Rovira, Nico M. Wulffraat, Majid Kazmi, Raffaella Greco, Emilian Snarski, Tomas Kozak, Kirill Kirgizov, Tobias Alexander, Peter Bader, Riccardo Saccardi and Dominique Farge for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE)
Blood Advances 2017 1:2742-2755

Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Pugnet G, Castilla-Llorente C, Puyade M, Terriou L, Badoglio M, Deligny C, Guillaume-Jugnot P, Labeyrie C, Benzidia I, Faivre H, Lansiaux P, Marjanovic Z, Bourhis JH, Faucher C, Furst S, Huynh A, Martin T, Vermersch P, Yakoub-Agha I, Farge D.
Bull Cancer. 2017 Nov 21. pii: S0007-4551(17)30271-0

Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.
Keever-Taylor CA, Heimfeld S, Steinmiller KC, Nash RA, Sullivan KM, Czarniecki CW, Granderson TC, Goldstein JS, Griffith LM.
Biol Blood Marrow Transplant. 2017 Sep;23(9):1463-1472

Oral health of adult patients undergoing hematopoietic cell transplantation. Pre-transplant assessment and care.
Boguslawska-Kapala A, Halaburda K, Rusyan E, Golabek H, Struzycka I
Ann Hematol. 2017 Jul;96(7):1135-1145.

Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications.
Cagliani J, Grande D, Molmenti EP, Miller EJ, Rilo HLR.
Ann Hematol. 2017 Jul;96(7):1135-1145.

2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M.
Bone Marrow Transplant. 2016 Jun;51(6):786-92. doi: 10.1038/bmt.2016.20.

Mesenchymal stem cells for treating autoimmune diseases: The Chinese experience from lab to clinics.
Liang J, Wang D, Farge D, Sun L.
Curr Res Transl Med. 2016 Apr-Jun;64(2):115-20

Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases.
Arruda LC, Clave E, Moins-Teisserenc H, Douay C, Farge D, Toubert A.
Curr Res Transl Med. 2016 Apr-Jun;64(2):107-13. doi: 10.1016/j.retram.2016.03.004.

Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice.
Kelsey PJ, Oliveira MC, Badoglio M, Sharrack B, Farge D, Snowden JA.
Curr Res Transl Med. 2016 Apr-Jun;64(2):71-82. doi: 10.1016/j.retram.2016.03.003.

Tumor necrosis factor inhibitors added to nonbiological immunosuppressants vs. nonbiological immunosuppressants alone: a different signal of cancer risk according to the condition. A disproportionality analysis in a nationwide pharmacovigilance database.
Saliba L, Moulis G, Abou Taam M, Rousseau V, Chebane L, Petitpain N, Baldin B, Pugnet G, Montastruc JL, Bagheri H.
Fundam Clin Pharmacol. 2016 Apr;30(2):162-71. doi: 10.1111/fcp.12171.

The use of hematopoietic stem cells in autoimmune diseases.
Ben Nasr M, Bassi R, Usuelli V, Valderrama-Vasquez A, Tezza S, D’Addio F, Fiorina P.
Regen Med. 2016 Jun;11(4):395-405

2015
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.
Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C, Falkenburg JH, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Marsh JC, Nagler A, Peters C, Velardi A, Mohty M, Madrigal A.
Bone Marrow Transplant. 2015 Aug;50(8):1037-56. doi: 10.1038/bmt.2015.6.

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Falkenburg JH, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M; European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2015 Apr;50(4):476-82. doi: 10.1038/bmt.2014.312.

Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP).
Snarski E, Snowden JA, Oliveira MC, Simoes B, Badoglio M, Carlson K, Burman J, Moore J, Rovira M, Clark RE, Saiz A, Hadj-Khelifa S, Tan J, Crescimanno A, Musso M, Martin T, Farge D.
Bone Marrow Transplant. 2015 Feb;50(2):216-20. doi: 10.1038/bmt.2014.248.

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking.
Alexander T, Bondanza A, Muraro PA, Greco R, Saccardi R, Daikeler T, Kazmi M, Hawkey C, Simoes BP, Leblanc K, Fibbe WE, Moore J, Snarski E, Martin T, Hiepe F, Velardi A, Toubert A, Snowden JA, Farge D
Bone Marrow Transplant. 2015 Feb;50(2):173-80. doi: 10.1038/bmt.2014.251.

2014
Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC.
Farge D, Terriou L, Badoglio M, Cras A, Desreumaux P, Hadj-Khelifa S, Marjanovic Z, Moisan A, Dulery R, Faucher C, Hij A, Martin T, Vermersch P, Yakoub-Agha I; SFGM-TC.
Pathol Biol (Paris). 2014 Aug;62(4):204-8. doi: 10.1016/j.patbio.2014.05.012.

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation.
Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Farge-Bancel D, Gennery A, Halter J, Kröger N, Lanza F, Marsh J, Mohty M, Sureda A, Velardi A, Madrigal A; European Society for Blood and Marrow Transplantation EBMT.
Bone Marrow Transplant. 2014 Jun;49(6):744-50. doi: 10.1038/bmt.2014.55.

2013
Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application.
Ménard C, Tarte K.
Stem Cell Res Ther. 2013 Jun 6;4(3):64

Progranulin antibodies in autoimmune diseases.
Thurner L, Preuss KD, Fadle N, Regitz E, Klemm P, Zaks M, Kemele M, Hasenfus A, Csernok E, Gross WL, Pasquali JL, Martin T, Bohle RM, Pfreundschuh M.
J Autoimmun. 2013 May;42:29-38. doi: 10.1016/j.jaut.2012.10.003.

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation.
Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA, Carlson K, Cornillon J, Diez-Martin JL, Gandemer V, Faraci M, Lindemans C, O’Meara A, Mialou V, Renard M, Sedlacek P, Sirvent A, Socié G, Sora F, Varotto S, Sanz J, Voswinkel J, Vora A, Yesilipek MA, Herr AL, Gluckman E, Farge D, Rocha V.
Blood. 2013 Feb 7;121(6):1059-64. doi: 10.1182/blood-2012-07-445965.

2012
The EBMT activity survey: 1990-2010.
Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, de Witte T, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A; European Group for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2012 Jul;47(7):906-23. doi: 10.1038/bmt.2012.66.

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.
Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, Denton C, Hawkey C, Labopin M, Mancardi G, Martin R, Moore JJ, Passweg J, Peters C, Rabusin M, Rovira M, van Laar JM, Farge D; EBMT Autoimmune Disease Working Party (ADWP); Paediatric Diseases Working Party (PDWP).
Bone Marrow Transplant. 2012 Jun;47(6):770-90. doi: 10.1038/bmt.2011.185.

Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009.
Snowden JA, Pearce RM, Lee J, Kirkland K, Gilleece M, Veys P, Clark RE, Kazmi M, Abinun M, Jackson GH, Mackinnon S, Russell NH, Cook G; BSBMT Clinical Trials Committee.
Br J Haematol. 2012 Jun;157(6):742-6. doi: 10.1111/j.1365-2141.2012.09122.x.

Control of B cells expressing naturally occurring autoantibodies.
Pasquali JL, Martin T.
Adv Exp Med Biol. 2012;750:145-56. doi: 10.1007/978-1-4614-3461-0_11.

2011
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party.
Daikeler T, Labopin M, Di Gioia M, Abinun M, Alexander T, Miniati I, Gualandi F, Fassas A, Martin T, Schwarze CP, Wulffraat N, Buch M, Sampol A, Carreras E, Dubois B, Gruhn B, Güngör T, Pohlreich D, Schuerwegh A, Snarski E, Snowden J, Veys P, Fasth A, Lenhoff S, Messina C, Voswinkel J, Badoglio M, Henes J, Launay D, Tyndall A, Gluckman E, Farge D; EBMT Autoimmune Disease Working Party.
Blood. 2011 Aug 11;118(6):1693-8. doi: 10.1182/blood-2011-02-336156.

2010
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis.
Tappenden P, Saccardi R, Confavreux C, Sharrack B, Muraro PA, Mancardi GL, Kozak T, Farge-Bancel D, Madan J, Rafia R, Akehurst R, Snowden J.
Bone Marrow Transplant. 2010 Jun;45(6):1014-21. doi: 10.1038/bmt.2009.305.

2009
Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors.
Avanzini MA, Bernardo ME, Cometa AM, Perotti C, Zaffaroni N, Novara F, Visai L, Moretta A, Del Fante C, Villa R, Ball LM, Fibbe WE, Maccario R, Locatelli F.
Haematologica. 2009 Dec;94(12):1649-60. doi: 10.3324/haematol.2009.006171.

Allogeneic hematopoietic SCT for patients with autoimmune diseases.
Daikeler T, Hügle T, Farge D, Andolina M, Gualandi F, Baldomero H, Bocelli-Tyndall C, Brune M, Dalle JH, Urban C, Ehninger G, Gibson B, Linder B, Lioure B, Marmont A, Matthes-Martin S, Nachbaur D, Schuetz P, Tyndall A, van Laar JM, Veys P, Saccardi R, Gratwohl A; Working Party Autoimmune Diseases of the EBMT.
Bone Marrow Transplant. 2009 Jul;44(1):27-33. doi: 10.1038/bmt.2008.424.

Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?
Larghero J, Vija L, Lecourt S, Michel L, Verrecchia F, Farge D.
Rev Med Interne. 2009 Mar;30(3):287-99. doi: 10.1016/j.revmed.2008.08.019

2005
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X; Club Rheumatismes et Inflammation (CRI).
Ann Rheum Dis. 2005 Jun;64(6):913-20.

Autologous hematopoietic stem cell transplantation for autoimmune diseases.
Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J, Kötter I, Kozak T, Lisukov I, Löwenberg B, Marmont A, Moore J, Saccardi R, Snowden JA, van den Hoogen F, Wulffraat NM, Zhao XW, Tyndall A; Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2005 May;35(9):869-79.

Progress in hematopoietic stem cell transplantation for autoimmune diseases
Tyndall A, Farge D.
Expert Rev Clin Immunol. 2005 May; 1(1):159-67. doi: 10.1586/1744666X.1.1.159.

2004
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis.
Saccardi R, Tyndall A, Coghlan P, Denton C, Edan G, Emdin M, Farge D et al.
Bone Marrow Transplant. 2004 Nov;34(10):877-81.

Antiphospholipid antibodies: recent progresses on their origin and pathogenicity.
Pasquali JL, Nehme H, Korganow AS, Martin T.
Joint Bone Spine. 2004 May;71(3):172-4.

2003
Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals.
Lieby P, Soley A, Knapp AM, Cerutti M, Freyssinet JM, Pasquali JL, Martin T.
Blood. 2003 Oct 1;102(7):2459-65. Epub 2003 Jun 5.

1999
From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins.
Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali JL, Benoist C, Mathis D.
Immunity. 1999 Apr;10(4):451-61.

1994
Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain.
Martin T, Crouzier R, Weber JC, Kipps TJ, Pasquali JL.
J Immunol. 1994 Jun 15;152(12):5988-96.

1992
Evidence for somatic selection of natural autoantibodies.
Martin T, Duffy SF, Carson DA, Kipps TJ.
J Exp Med. 1992 Apr 1;175(4):983-91.